May 18, 2016
Lilly Oncology has retained The Chase Group once again to conduct an external search for two physicians to join their Medical Affairs/Late Phase Product Development Division with expertise in thoracic cancer and breast cancer. Physicians that we recruit into these roles will serve as the external face of Eli Lilly with the priority to advance patient care and outcome of these cancers. The recruiting team at Chase is proud to play an integral role in the process of bringing the patients and the disease to the forefront of Eli Lilly’s research because we, too, have been impacted by the negative forces of these cancers.
